LivaNova PLC Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by LivaNova PLC on March 15, 2018. The filing details the approval of executive compensation adjustments and incentive plans by the Compensation Committee of the Board of Directors.
Key Financial Metrics and Compensation Data
The filing does not report company-wide revenue, profit, cash flow, or debt metrics. It focuses exclusively on executive compensation figures:
- 2017 Short-Term Incentive (STI) Payouts Approved:
- CEO Damien McDonald: GBP 658,132
- CFO Thad Huston: GBP 209,244
- Named Executive Officer David Wise: USD 304,996
- 2018 Base Salary Adjustments (Effective April 1, 2018):
- Mr. McDonald: GBP 731,500 (11% increase from 2017)
- Mr. Huston: GBP 386,250 (3% increase from 2017)
- Mr. Wise: USD 465,000 (3% increase from 2017)
- 2018 STI Target Percentages:
- Mr. McDonald: 100% of base salary
- Mr. Huston: 90% of base salary
- Mr. Wise: 70% of base salary
Material Changes and Unusual Items
2017 STI Calculation Adjustment: The Committee excluded the financial performance of the Cardiac Rhythm Management (CRM) Franchise from the 2017 STI calculation due to anomalous performance compared to the rest of the company. Additionally, an incremental payment of GBP 3,948 was made to Mr. McDonald to align his payout percentage with other named executive officers, resulting in individual payout increases between 4.9% and 7.2%.
2018 Long-Term Incentive Plan (LTIP): The Committee approved the 2018 LTIP, granting equity awards including service-based restricted stock units, stock appreciation rights, and performance stock units tied to relative total shareholder return and three-year cumulative adjusted free cash flow targets.
Management Commentary and Risks
Management benchmarked executive compensation against independent data from Pearl Meyer & Partners, LLC. Mr. McDonald's target total cash ranked at the 64th percentile (UK) and 65th percentile (US). Mr. Huston's target ranked at the 55th percentile (UK) and above the 75th percentile (US). Mr. Wise's target ranked at the 56th percentile (US). The filing does not disclose specific forward-looking guidance or new risk factors beyond standard compensation plan terms.
Investor Verification Checklist
- Verify the specific terms of the 2018 LTIP in Exhibit 10.1, particularly the performance metrics for the free cash flow and relative total shareholder return targets.
- Review the rationale for excluding the Cardiac Rhythm Management (CRM) franchise from 2017 performance calculations to understand the impact on future bonus structures.
- Confirm the effective date of the 2018 base salary increases (April 1, 2018) against payroll records.
- Assess the alignment of executive pay with the company's overall financial performance given the exclusion of CRM results in the prior year.